DOI:
10.1055/s-00000034
Klinische Pädiatrie
LinksClose Window
References
Pegram MD, Lipton A, Hayes DF et al.
Phase II study of receptor-enhanced chemosensitivity using recombinant humanized anti-p185HER2/neu monoclonal antibody plus cisplatin in patients with HER2/neu-overexpressing metastatic breast cancer refractory to chemotherapy treatment.
J Clin Oncol 1998;
16: 2659-2671
We do not assume any responsibility for the contents of the web pages of other providers.